JP6116691B2 - 濃縮物質を含む容器及びその使用方法 - Google Patents
濃縮物質を含む容器及びその使用方法 Download PDFInfo
- Publication number
- JP6116691B2 JP6116691B2 JP2015530093A JP2015530093A JP6116691B2 JP 6116691 B2 JP6116691 B2 JP 6116691B2 JP 2015530093 A JP2015530093 A JP 2015530093A JP 2015530093 A JP2015530093 A JP 2015530093A JP 6116691 B2 JP6116691 B2 JP 6116691B2
- Authority
- JP
- Japan
- Prior art keywords
- container body
- contrast agent
- concentrated
- volume
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/54—Inspection openings or windows
- B65D25/56—Inspection openings or windows with means for indicating level of contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0046—Cups, bottles or bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0404—X-ray contrast preparations containing barium sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
- A61K49/105—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
- A61K49/108—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/816—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package into which liquid is added and the resulting preparation is retained, e.g. cups preloaded with powder or dehydrated food
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
- G01F19/00—Calibrated capacity measures for fluids or fluent solid material, e.g. measuring cups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Mechanical Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
本願は、2012年8月30日に出願された「CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME」という名称の米国特許出願(U.S. Utility Application)第13/599,045号に対する優先権の利益を主張するものであり、該出願の一部継続(CIP)出願であり、その開示の全体が本明細書に参考として取り込まれる。
いくつかの実施形態では、本明細書に記載の器具及び方法は、脱水症に対処するための経口補水塩とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適な経口補水塩を含有し、また、中に含まれる経口補水塩の再構成及び/又は投与に関する1つ又は複数の表示を有する。
いくつかの実施形態では、本明細書に記載の器具及び方法は、栄養補給剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適な栄養補給剤を含有し、また中に含まれる栄養補給剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
いくつかの実施形態では、本明細書に記載の器具及び方法はOGTT製剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適なOGTT製剤を含有し、また中に含まれるOGTT製剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
いくつかの実施形態では、本明細書に記載の器具及び方法は腸洗浄製剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適な腸洗浄製剤を含有し、また中に含まれる腸洗浄製剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
いくつかの実施形態では、本明細書に記載の器具及び方法は、結腸直腸検査及び/又は腹部手術等のための緩下製剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適な緩下製剤を含有し、また中に含まれる緩下製剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
いくつかの実施形態では、本明細書に記載の器具及び方法は、腸機能の改善及び/又は高アンモニア血症の治療のための製剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、腸機能の改善及び/又は高アンモニア血症の治療のための任意の好適な製剤を含有し、また中に含まれる腸機能の改善及び/又は高アンモニア血症の治療のための製剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
に伴う脳波異常(abnormal electricencepharogram)、産婦人科における排ガス又は排泄の術後促進の処置、及び小児科における便秘の改善に有用である。
いくつかの実施形態では、本明細書に記載の器具及び方法は、粘膜保護剤及び/又は止血製剤とともに使用可能である。同様にいくつかの実施形態では、本明細書に記載されるような器具は、任意の好適な粘膜保護剤及び/又は止血製剤を含有し、また中に含まれる粘膜保護剤及び/又は止血製剤の再構成及び/又は投与に関する1つ又は複数の表示を有する。
Claims (13)
- (A)容器本体の内部と流体連通している開口部を画定し、且つ、該容器本体の内部に粉末形態の単位用量の濃縮造影剤を含有する容器本体、
(B)前記容器本体に取り付けて前記開口部を封鎖するキャップ、ならびに、
(C)前記容器本体及び前記キャップが内部に共に配置され、前記濃縮造影剤を光及び/又は湿気から保護する遮蔽部材、
を含み、
(D)ここで、前記濃縮造影剤はヨード造影剤であり、
前記容器本体の内部は、前記濃縮造影剤を選択された希釈濃度へと希釈するための或る容量の液体を前記開口部を通って受容し、前記容器本体を振り動かすことで前記液体と前記濃縮造影剤とを混合できるヘッドスペースを備えており、
前記濃縮造影剤は、前記開口部を通って前記容器本体の内部に受容可能な或る容量の液体によって選択希釈濃度へと希釈されるように構成されており、
(E)使用者によって前記容器本体から経口摂取される濃縮造影剤を提供するための器具。 - 前記ヨード造影剤がイオヘキソールである、請求項1に記載の器具。
- 前記濃縮造影剤が機能的賦形剤又は添加剤を含まない、請求項1または2に記載の器具。
- イオヘキソールの単位用量が、80mL〜2000mLの受容可能な容量の前記液体では0.5gI〜25gIである、請求項2または3に記載の器具。
- イオヘキソールの単位用量が、4mL〜250mLの受容可能な容量の前記液体では0.2gI〜75gIである、請求項2または3に記載の器具。
- 前記容器本体が、濃縮造影剤が前記或る容量の液体で希釈されている場合に、前記容器本体の開口部を通して濃縮造影剤を経口摂取することで患者により使用されるように構成されている、請求項1〜5のいずれかに記載の器具。
- 前記容器本体が、少なくとも透明な部分と、該透明な部分の上に配置された複数の表示とを含み、該複数の表示のそれぞれの表示が、濃縮造影剤の単位用量の対応する既定の希釈を達成できるような、該容器本体の内部に受容される液体の容量に対応するものである、請求項1〜6のいずれかに記載の器具。
- 前記容器本体が少なくとも透明な部分を含み、前記器具が更に、
前記容器本体上に配置されたラベルを備えるとともに複数の表示を含み、該複数の表示のそれぞれが、濃縮造影剤の単位用量の対応する既定の希釈を達成できるような、該容器本体の内部に受容される液体の容量に対応するものであり、該複数の表示が前記透明な部分に隣接した前記ラベル上に配置されている、請求項1〜7のいずれかに記載の器具。 - 前記遮蔽部材がポリマー及びアルミニウムのラミネートを含む、請求項1〜8のいずれかに記載の器具。
- 前記遮蔽部材が超音波シール及びヒートシールの一方により封着されている、請求項1〜8のいずれかに記載の器具。
- 単位用量の濃縮造影剤を光及び/又は湿気から遮るように構成されている遮蔽部材の内部から、キャップが上に配置された容器本体を取り出す工程、
ここで該容器本体は、該容器本体の内部に粉末形態の単位用量の濃縮造影剤を有しており、該濃縮造影剤はヨード造影剤であり、該容器本体の内部は濃縮造影剤を選択された希釈濃度へと希釈するための或る容量の液体を該容器本体の開口部を通って受容し、該容器本体を振り動かすことで該液体と該濃縮造影剤とを混合できるヘッドスペースを備えている、
該容器本体からキャップを取り外す工程、
濃縮造影剤が選択希釈濃度へと希釈されるように、或る容量の液体を前記容器本体の内部に加える工程、ならびに
前記容器本体を使用者に提供する工程、
とを含む、
使用者によって前記容器本体から経口摂取される濃縮造影剤を提供する方法。 - 前記或る容量の液体を加えた後、前記キャップを前記容器本体に取り付けることと、
前記或る容量の液体が濃縮造影剤と混合されるように前記容器本体を振り動かすことと、
を更に含む、請求項11に記載の方法。 - 前記濃縮造影剤が粉末形態のイオヘキソールである、請求項11または12に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/599,045 | 2012-08-30 | ||
US13/599,045 US20140065076A1 (en) | 2012-08-30 | 2012-08-30 | Container with concentrated substance and method of using the same |
PCT/US2013/057529 WO2014036402A1 (en) | 2012-08-30 | 2013-08-30 | Container with concentrated substance and method of using the same |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015528351A JP2015528351A (ja) | 2015-09-28 |
JP2015528351A5 JP2015528351A5 (ja) | 2016-08-25 |
JP6116691B2 true JP6116691B2 (ja) | 2017-04-19 |
Family
ID=49209541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015530093A Expired - Fee Related JP6116691B2 (ja) | 2012-08-30 | 2013-08-30 | 濃縮物質を含む容器及びその使用方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20140065076A1 (ja) |
EP (1) | EP2890354B1 (ja) |
JP (1) | JP6116691B2 (ja) |
CA (1) | CA2883391C (ja) |
ES (1) | ES2592705T3 (ja) |
RU (1) | RU2646826C2 (ja) |
TW (1) | TWI581787B (ja) |
WO (1) | WO2014036402A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10350311B2 (en) | 2014-03-04 | 2019-07-16 | Otsuka Pharmaceutical Co., Ltd. | Iohexol powder and method of using the same |
US20160060022A1 (en) * | 2014-08-27 | 2016-03-03 | John Frank Stagl | Apparatus for providing cocktail mix |
US11090130B2 (en) * | 2015-10-09 | 2021-08-17 | Oregon State University | Fiducial marker for computed tomography and magnetic resonance imaging |
GB201703227D0 (en) * | 2017-01-20 | 2017-04-12 | Ge Healthcare As | Plastic containers |
US10947012B1 (en) | 2019-04-23 | 2021-03-16 | Express Scripts Strategic Development, Inc. | Container with fill gauge |
RU2715386C1 (ru) * | 2019-04-26 | 2020-02-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) | Упаковка для мягкой лекарственной формы индивидуального изготовления |
JP7444554B2 (ja) * | 2019-06-21 | 2024-03-06 | 大和製罐株式会社 | 難溶性飲料製品 |
CN110559188A (zh) * | 2019-09-17 | 2019-12-13 | 长沙凯泽工程设计有限公司 | 一种药物提取装置 |
KR102523963B1 (ko) * | 2020-01-03 | 2023-04-21 | 이화여자대학교 산학협력단 | 이종 약물을 혼합하기 위한 안약 용기 |
JP1698880S (ja) | 2020-05-15 | 2021-11-08 | ||
GB2601578A (en) * | 2020-05-15 | 2022-06-08 | Procter & Gamble | Refillable product containing dissolvable solid article |
CA3117023A1 (en) * | 2020-05-15 | 2021-11-15 | The Procter & Gamble Company | Product containing dissolvable solid article |
JP2023538037A (ja) | 2020-09-10 | 2023-09-06 | ザ プロクター アンド ギャンブル カンパニー | 抗細菌活性物質を含有する溶解性固体物品 |
CN113069129B (zh) * | 2021-02-26 | 2023-04-11 | 四川省肿瘤医院 | 一种18f-fdg pet/ct检查去除胃内伪影的方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL127881C (ja) * | 1963-03-25 | |||
FR2298840A1 (fr) * | 1975-01-22 | 1976-08-20 | Beaudoux Maurice | Etiquette pour recipient transparent ou translucide contenant un produit a doser |
DE3776020D1 (en) * | 1986-07-15 | 1992-02-27 | Fausto Spoleto It Gallina | Container administering barium sulphate suspension and air |
JPH0674213B2 (ja) * | 1988-07-05 | 1994-09-21 | マナック株式会社 | 消化管用固形x線造影剤 |
JPH02261801A (ja) * | 1989-04-03 | 1990-10-24 | Tetsuo Suami | 低粘度ヨード化ヒドロキシエチル澱粉およびその製法 |
GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
JPH0734816B2 (ja) * | 1991-06-26 | 1995-04-19 | 新田ゼラチン株式会社 | 医科用および歯科用硬化性材料 |
DK0661051T3 (da) * | 1993-10-11 | 2006-05-22 | Viatris Gmbh | Medikament til behandling af hypertension |
MY132225A (en) * | 1995-03-13 | 2007-09-28 | Amersham Health Inc | Contrast agent for ultrasonography |
US5847212A (en) * | 1997-04-21 | 1998-12-08 | Abbott Laboratories | Process for the preparation of iohexol |
JP3559966B2 (ja) * | 2001-07-11 | 2004-09-02 | 堀井薬品工業株式会社 | 注腸造影法に用いる造影剤容器 |
ATE556943T1 (de) * | 2002-08-08 | 2012-05-15 | Concept & Design Ltd | Tragbare getränkezubereitungsvorrichtung und entsprechendes system |
NO20033058D0 (no) * | 2003-07-03 | 2003-07-03 | Amersham Health As | Prosess |
CN100344322C (zh) * | 2004-05-27 | 2007-10-24 | 姜叶东 | 治疗心脏病的药物及其制备方法 |
US8092839B2 (en) * | 2004-12-13 | 2012-01-10 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
GB2435027A (en) * | 2006-02-08 | 2007-08-15 | Shurbhi Shah | Container for use in administering medicine |
FR2899581B1 (fr) * | 2006-04-07 | 2008-06-27 | Guerbet Sa | Procede d'atomisation du ioxilan |
US20080044314A1 (en) * | 2006-06-23 | 2008-02-21 | Cephalon, Inc. | Pharmaceutical measuring and dispensing cup |
KR20080035926A (ko) * | 2006-10-20 | 2008-04-24 | 재단법인서울대학교산학협력재단 | 자성체 나노입자를 함유한 코어-외각 구조의 금 나노입자의자기공명영상의 티2 조영제, 암 진단제 및 암치료제로서의 용도 |
US7674434B2 (en) * | 2006-11-27 | 2010-03-09 | Cytyc Corporation | Vials and apparatus for obtaining an aliquot of a sample |
KR101018221B1 (ko) * | 2008-05-16 | 2011-02-28 | 한남대학교 산학협력단 | 금-증착된 산화철/글리콜 키토산 복합체, 이의 제조방법 및 이를 포함하는 mri 조영제 |
GB0913295D0 (en) * | 2009-07-30 | 2009-09-02 | Norgine Bv | Improvements in and relating to pharmaceutical compositions |
US9403624B2 (en) * | 2009-08-24 | 2016-08-02 | Beekley Corporation | Device and method for dispensing a beverage and imaging contrast agent |
JP2013126429A (ja) * | 2010-03-29 | 2013-06-27 | Morimoto Iyaku:Kk | 医薬組成物容器 |
CN202223624U (zh) * | 2011-08-31 | 2012-05-23 | 郑培省 | 调压洗肠器 |
CN102580120B (zh) * | 2012-03-21 | 2014-04-02 | 海南医学院附属医院 | 一种靶向性mri对比剂及其制备方法 |
-
2012
- 2012-08-30 US US13/599,045 patent/US20140065076A1/en not_active Abandoned
-
2013
- 2013-07-03 US US13/934,654 patent/US20140065077A1/en not_active Abandoned
- 2013-08-30 RU RU2015111256A patent/RU2646826C2/ru active
- 2013-08-30 ES ES13763147.9T patent/ES2592705T3/es active Active
- 2013-08-30 CA CA2883391A patent/CA2883391C/en not_active Expired - Fee Related
- 2013-08-30 JP JP2015530093A patent/JP6116691B2/ja not_active Expired - Fee Related
- 2013-08-30 WO PCT/US2013/057529 patent/WO2014036402A1/en active Application Filing
- 2013-08-30 TW TW102131377A patent/TWI581787B/zh not_active IP Right Cessation
- 2013-08-30 EP EP13763147.9A patent/EP2890354B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
ES2592705T3 (es) | 2016-12-01 |
JP2015528351A (ja) | 2015-09-28 |
EP2890354B1 (en) | 2016-07-20 |
RU2015111256A (ru) | 2016-10-20 |
US20140065076A1 (en) | 2014-03-06 |
EP2890354A1 (en) | 2015-07-08 |
US20140065077A1 (en) | 2014-03-06 |
TWI581787B (zh) | 2017-05-11 |
CA2883391C (en) | 2020-12-29 |
WO2014036402A1 (en) | 2014-03-06 |
TW201410232A (zh) | 2014-03-16 |
RU2646826C2 (ru) | 2018-03-07 |
CA2883391A1 (en) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6116691B2 (ja) | 濃縮物質を含む容器及びその使用方法 | |
US10898515B2 (en) | Colon lavage system | |
US11135411B1 (en) | Device and method for dispensing a beverage and imaging contrast agent | |
JP5870119B2 (ja) | 腸洗浄のための、方法、組成物、およびパッケージ | |
JPH0225424A (ja) | 腸管洗浄液用組成物と腸管洗浄液 | |
EP2626085A1 (en) | Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging digestive tract | |
WO2000013529A1 (fr) | Produits alimentaires anti-emetiques | |
US20150343096A1 (en) | Liquid preparation for oral administration for use in ct colonography, and composition for imaging digestive tract | |
JPH03206046A (ja) | 腸管洗浄液用組成物及び腸管洗浄液 | |
NO312177B1 (no) | Pakke klar for oral administrasjon | |
US20130052143A1 (en) | Liquid preparation for oral administration to be used in ct colonography, and composition for digestive tract imaging | |
US20050180920A1 (en) | Oral contrast media composition for computerized axial tomographic examinations and method | |
JP2005002006A (ja) | Ctコロノグラフィにおける消化管造影用組成物 | |
US20200352855A1 (en) | Colon Cleansing Composition and Methods of Using Same | |
JP2012144573A (ja) | Ctコロノグラフィにおける消化管造影用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160705 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160705 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20160705 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20160818 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161018 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20161207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170215 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170228 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170321 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6116691 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |